Koo, E., & Macdonald, D. A. (2024). Maintenance Therapy for CD20+ Indolent Lymphoma: Who Should Receive Maintenance?. Canadian Hematology Today, 3(1), 44–50. https://doi.org/10.58931/cht.2024.3150